ArticleFrontiers in medicine2026
Adaptive multi-stage domain unlearning for white-matter lesion segmentation.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Inter-scanner variability in magnetic resonance imaging (MRI) adversely affects the diagnostic and prognostic quality of scans and necessitates the development of models that are robust to domain shift arising from the unseen scanner data. A review of recent advances in domain adaptation and domain generalization showed that the efficacy of strategies involving modifications or constraints on the latent space appears to be contingent upon the level and/or depth of supervision during model training. Methods: We propose an adaptive multi-stage domain unlearning (ADMU) technique to improve robustness to unseen scanner domains. Building on the state-of-the-art segmentation framework nnU-Net, we employ deep supervision at deep encoder stages by applying domain classifier unlearning, sequentially across these stages to reduce domain-discriminative latent features. Following the self-configurable approach of nnU-Net, the auxiliary feedback loop implements an adaptive backpropagation schedule for unlearning. Experiments were conducted on four public datasets (one for training, three for testing) to benchmark white-matter lesion segmentation methods. Five benchmark models and/or strategies, spanning passive to active domain-robust training strategies, were tested, and five state-of-the-art methods were compared. Results: AMDU demonstrated consistent, robust and improved cross-dataset segmentation performance on three test sets versus baseline nn-Unet variants. The advantage of AMDU was in enhanced lesion sensitivity with balanced false detections, resulting in good overall segmentation quality, as measured by segmentation overlap and relative lesion volume error. Compared to continuous domain unlearning, the adaptive scheduling balanced the adverse impact of unlearning onto the main segmentation task. Intensity-based preprocessing was found to be detrimental to segmentation performance. Discussion: The proposed AMDU strategy was shown to be complementary to data augmentation. Demonstrated for white-matter lesion segmentation it relied only the FLAIR modality, simplifying preprocessing to spatial normalization to brain atlas, with no intensity harmonization, for best cross-dataset segmentation performance. The source code is available at https://github.com/Pubec/nnunetv2-unlearning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.